Author

A. Zylicz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Jaiswar· 1 shared D. Walerych· 1 shared J. Legierska· 1 shared J. R. Wisniewski· 1 shared K. Jastrzebski· 1 shared K. Zettl· 1 shared M. Cybulska· 1 shared M. Grochowski· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Jaiswar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The response network of HSP70 defines vulnerabilities in cancer cells with the inhibited proteasome

M. Oron, M. Grochowski, A. Jaiswar, J. Legierska, K. Jastrzebski, M. Nowak-Niezgoda, M. Kolos, W. Kazmierczak, T. Olesinski, M. Lenarcik, M. Cybulska, M. Mikula, A. Zylicz, M. Miaczynska, K. Zettl, , D. Walerych

The paper identifies HSP70 as a vulnerability in cancer cells under proteasome inhibition, showing its role in suppressing drug effects and linking its expression to patient risk.

bioRxiv · Nov 16, 2021Cancer Biology